Cognizant Says It is Recognized as Leader in Life Science Drug Safety Services

Cognizant (NASDAQ:CTSH) announced today that the company has been recognized as a leader in the IDC Health Insights known as “IDC MArketScape: Worldwide Life Science Drug Safety Services 2013 Vendor Assessment.”

As quoted in the press release:

While possessing demonstrated experience across the complete life science value chain, Cognizant is strongest in its BPO and IT service offerings to the industry,” said the report. “Cognizant’s life science drug safety services team is the largest in the industry, a result of the company’s success in delivering higher-value drug safety services to its clients. This, combined with Cognizant’s strong investment-supporting growth and significant commitment to development of industry-centric intellectual property, ensures that the company can be expected to remain a leader in the field for years to come,” the report added.

Click here to read the full Cognizant (NASDAQ:CTSH) press release.